Concepedia

Author

Nicola Giuliani

University of ParmaORCID

Also Known As

Giuliani, Giuliani, Nicola, M Giuliani, M. Giuliani, N Giuliani, N. GIULIANI, N. Giuliani, N. Giuliani, M. Pedrazzoni, G. Pass, Nicola Giuliani

400

Publications

11.3K

Citations

61

H-Index

126

Concepts

All Affiliations

University of ParmaOspedale di ParmaUniversity of MilanIstituti di Ricovero e Cura a Carattere ScientificoFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
NG

About

Nicola Giuliani is an author at University of Parma specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

31

45

3.1K

2

Health Sciences

12

15

924

3

Public Health

3

3

350

4

Engineering

1

1

90

5

Natural Sciences

1

1

72

Nicola Giuliani

×

115

Publications

8.9K

Citations

56

H-Index

YearCitations

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini,

The Lancet Haematology

2020

551

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

Nicola Giuliani, Régis Bataille, Cristina Mancini,

Blood

2001

413

Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation

Nicola Giuliani, Simona Colla, Francesca Morandi,

Blood

2005

316

Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network

Antonio Palumbo, Patrizia Falco, Paolo Corradini,

Journal of Clinical Oncology

2007

316

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients

Nicola Giuliani, Francesca Morandi, Sara Tagliaferri,

Blood

2007

275

Bisphosphonates Stimulate Formation of Osteoblast Precursors and Mineralized Nodules in Murine and Human Bone Marrow Cultures In Vitro and Promote Early Osteoblastogenesis in Young and Aged Mice In Vivo

Nicola Giuliani, Mario Pedrazzoni, G. Negri,

Bone

1998

268

Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

Nicola Giuliani, Simona Colla, Roberto Sala,

Blood

2002

265

The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition

Giada Bianchi, Laura Oliva, Paolo Cascio,

Blood

2009

262

IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

Lori A. Ehrlich, Ho Yeon Chung, Irene M. Ghobrial,

Blood

2005

203

Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients

Antonio Palumbo, Francesca Gay, Patrizia Falco,

Journal of Clinical Oncology

2010

174

Page 1